Detail Cantuman
Pencarian Spesifik
Text
GAMBARAN PENGGUNAAN ANTIBIOTIK DAN ANTIVIRUS PADA PASIEN RAWAT INAP COVID-19 DI RSI SULTAN AGUNG SEMARANG PERIODE APRIL - DESEMBER 2020
The case of pneumonia caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) which is called coronavirus diseases 2019 (COVID-
19) by the World Health Organization (WHO) is a tragedy in the global health
world. Appropriate and prompt management is expected to save the patient's life.
The spread of this disease has had a wide impact both economically and
economically. There is still a lot of controversy surrounding this disease, including
aspects of diagnosis, management, and prevention. This study aims to describe
the use of antibiotics and antivirals in inpatients of COVID-19 at Sultan Agung
Hospital for the period April – December 2020.
This research is a descriptive non-experimental research. The approach was
carried out retrospectively based on the patient's medical record data. The data
was taken at RSI Sultan Agung Semarang for the period April – December 2020.
The data obtained were then presented in tabular form.
The results showed that the most COVID-19 patients were patients with male
gender, namely 51%, and the most were in the 51-60 year age range by 28%.
Covid-19 patients who were hospitalized at the Sultan Agung Hospital for the
April-December 2020 period were diagnosed with comorbidities at 81%. The
most widely used antibiotic drug was Levofloxacin 59% while the most widely
used antiviral was Favipiravir 85%
Keywords: COVID-19, management, therapy.
Ketersediaan
KTI000896 | 615.4 PRI P | My Library | Tersedia |
Informasi Detail
Judul Seri |
-
|
---|---|
No. Panggil |
615.4 PRI P
|
Penerbit | STIFERA : SEMARANG., 2021 |
Deskripsi Fisik |
-
|
Bahasa |
Indonesia
|
ISBN/ISSN |
-
|
Klasifikasi |
615.4 PRI P
|
Tipe Isi |
-
|
Tipe Media |
-
|
---|---|
Tipe Pembawa |
-
|
Edisi |
-
|
Subjek |
-
|
Info Detail Spesifik |
-
|
Pernyataan Tanggungjawab |
-
|
Versi lain/terkait
Tidak tersedia versi lain